Literature DB >> 16978941

Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.

Heather R Macdonald1, Melvin J Silverstein, Laura A Lee, Wei Ye, Premal Sanghavi, Dennis R Holmes, Howard Silberman, Michael Lagios.   

Abstract

BACKGROUND: A previous study showed a 3% local recurrence risk at 8 years in ductal carcinoma in situ (DCIS) patients treated with excision alone with surgical margins of 10 mm or greater. This study updates those data.
METHODS: A total of 272 DCIS patients treated conservatively with 10 mm or greater margins were reviewed in a prospective database.
RESULTS: Among 212 excision-alone patients, there were 9 DCIS and 3 invasive recurrences. The 12-year probability of any local recurrence was 13.9%; of invasive recurrence it was 3.4%. Among 60 excision plus radiation patients, there was 1 local (invasive) recurrence (P = .06). The 12-year probability of local recurrence was 2.5%.
CONCLUSIONS: Local recurrence in DCIS patients treated with excision alone with margins of 10 mm or greater compares favorably with local recurrence in DCIS patients with nontransected margins and treated with postoperative radiation. The risk of invasive recurrence among widely excised DCIS patients is extremely low.

Entities:  

Mesh:

Year:  2006        PMID: 16978941     DOI: 10.1016/j.amjsurg.2006.06.031

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  11 in total

1.  HER2-Overexpressing Ductal Carcinoma In Situ Associated with Increased Risk of Ipsilateral Invasive Recurrence, Receptor Discordance with Recurrence.

Authors:  Thomas J O'Keefe; Sarah L Blair; Ava Hosseini; Olivier Harismendy; Anne M Wallace
Journal:  Cancer Prev Res (Phila)       Date:  2020-06-03

2.  Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.

Authors:  Paul Macklin; Mary E Edgerton; Alastair M Thompson; Vittorio Cristini
Journal:  J Theor Biol       Date:  2012-02-09       Impact factor: 2.691

Review 3.  Ductal Carcinoma In Situ: Treatment Update and Current Trends.

Authors:  Katrina B Mitchell; Henry Kuerer
Journal:  Curr Oncol Rep       Date:  2015-11       Impact factor: 5.075

Review 4.  Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

Authors:  Tatyana Shamliyan; Shi-Yi Wang; Beth A Virnig; Todd M Tuttle; Robert L Kane
Journal:  J Natl Cancer Inst Monogr       Date:  2010

5.  Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

Authors:  Lorie L Hughes; Molin Wang; David L Page; Robert Gray; Lawrence J Solin; Nancy E Davidson; Mary Ann Lowen; James N Ingle; Abram Recht; William C Wood
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

Review 6.  Margins in breast cancer: How much is enough?

Authors:  Melissa Pilewskie; Monica Morrow
Journal:  Cancer       Date:  2018-01-16       Impact factor: 6.860

7.  Risk stratification in ductal carcinoma in situ: the role of genomic testing.

Authors:  Gary M Freedman
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

8.  Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?

Authors:  Siwa Chan; Jeon-Hor Chen; Garima Agrawal; Muqing Lin; Rita S Mehta; Philip M Carpenter; Orhan Nalcioglu; Min-Ying Su
Journal:  J Oncol       Date:  2010-09-21       Impact factor: 4.375

9.  Clinical outcomes of ductal carcinoma in situ of the breast treated with partial mastectomy without adjuvant radiotherapy.

Authors:  Seung Hyun Hwang; Joon Jeong; Sung Gwe Ahn; Hak Min Lee; Hy-De Lee
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

10.  Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States.

Authors:  F Lee Tucker
Journal:  Int J Breast Cancer       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.